Moreover, silencing METTL3 promoted the proliferation of GSCs, which was achieved by the alternative splicing of isoform switches and modulating the nonsense-mediated mRNA decay of splicing factors in GBM [16,17]. The gene discussed is METTL3; the disease is glioblastoma.